180 related articles for article (PubMed ID: 23903763)
1. [Medicine from the computer].
Andrae K; Durmaz V; Fackeldey K; Scharkoi O; Weber M
Schmerz; 2013 Aug; 27(4):409-13. PubMed ID: 23903763
[TBL] [Abstract][Full Text] [Related]
2. [Medicine from the computer].
Andrae K; Durmaz V; Fackeldey K; Scharkoi O; Weber M
Anaesthesist; 2013 Jul; 62(7):557-61. PubMed ID: 23817844
[TBL] [Abstract][Full Text] [Related]
3. [Medicine from the computer].
Andrae K; Durmaz V; Fackeldey K; Scharkoi O; Weber M
Z Rheumatol; 2013 Oct; 72(8):809-13. PubMed ID: 24122221
[TBL] [Abstract][Full Text] [Related]
4. A Simple and Resource-efficient Setup for the Computer-aided Drug Design Laboratory.
Moretti L; Sartori L
Mol Inform; 2016 Oct; 35(10):489-494. PubMed ID: 27647771
[TBL] [Abstract][Full Text] [Related]
5. Structure-based drug design: docking and scoring.
Kroemer RT
Curr Protein Pept Sci; 2007 Aug; 8(4):312-28. PubMed ID: 17696866
[TBL] [Abstract][Full Text] [Related]
6. Pharmmaker: Pharmacophore modeling and hit identification based on druggability simulations.
Lee JY; Krieger JM; Li H; Bahar I
Protein Sci; 2020 Jan; 29(1):76-86. PubMed ID: 31576621
[TBL] [Abstract][Full Text] [Related]
7. Consensus scoring for protein-ligand interactions.
Feher M
Drug Discov Today; 2006 May; 11(9-10):421-8. PubMed ID: 16635804
[TBL] [Abstract][Full Text] [Related]
8. The use of protein-ligand interaction fingerprints in docking.
Brewerton SC
Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
[TBL] [Abstract][Full Text] [Related]
9. Computer-aided drug design platform using PyMOL.
Lill MA; Danielson ML
J Comput Aided Mol Des; 2011 Jan; 25(1):13-9. PubMed ID: 21053052
[TBL] [Abstract][Full Text] [Related]
10. CADD medicine: design is the potion that can cure my disease.
Manas ES; Green DV
J Comput Aided Mol Des; 2017 Mar; 31(3):249-253. PubMed ID: 28070730
[TBL] [Abstract][Full Text] [Related]
11. Predictive QSAR modeling workflow, model applicability domains, and virtual screening.
Tropsha A; Golbraikh A
Curr Pharm Des; 2007; 13(34):3494-504. PubMed ID: 18220786
[TBL] [Abstract][Full Text] [Related]
12. Current Opioid Overdose Crisis: Some Comments on the Chemicobiological Aspects of Tolerance/Dependence and Abuse Based on Computational Chemistry and Biology.
Basak SC; Kier LB
Curr Comput Aided Drug Des; 2018; 14(3):175-177. PubMed ID: 30062955
[No Abstract] [Full Text] [Related]
13. Structure-based drug design and modern medicine.
Vijayakrishnan R
J Postgrad Med; 2009; 55(4):301-4. PubMed ID: 20083886
[TBL] [Abstract][Full Text] [Related]
14. De Novo Design of Ligands Using Computational Methods.
Suryanarayanan V; Panwar U; Chandra I; Singh SK
Methods Mol Biol; 2018; 1762():71-86. PubMed ID: 29594768
[TBL] [Abstract][Full Text] [Related]
15. In silico design of small molecules.
Bernardo PH; Tong JC
Methods Mol Biol; 2012; 800():25-31. PubMed ID: 21964780
[TBL] [Abstract][Full Text] [Related]
16. Challenges and advances in computational docking: 2009 in review.
Yuriev E; Agostino M; Ramsland PA
J Mol Recognit; 2011; 24(2):149-64. PubMed ID: 21360606
[TBL] [Abstract][Full Text] [Related]
17. Protein flexibility and computer-aided drug design.
Wong CF; McCammon JA
Annu Rev Pharmacol Toxicol; 2003; 43():31-45. PubMed ID: 12142469
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in computer-aided drug design.
Song CM; Lim SJ; Tong JC
Brief Bioinform; 2009 Sep; 10(5):579-91. PubMed ID: 19433475
[TBL] [Abstract][Full Text] [Related]
19. Strategy of computer-aided drug design.
Veselovsky AV; Ivanov AS
Curr Drug Targets Infect Disord; 2003 Mar; 3(1):33-40. PubMed ID: 12570731
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and evaluation of biotinylated opioid derivatives as novel probes to study opioid pharmacology.
Li Y; Chase AR; Slivka PF; Baggett CT; Zhao TX; Yin H
Bioconjug Chem; 2008 Dec; 19(12):2585-9. PubMed ID: 19090701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
